Prior Authorization Automation Is Only as Good as the Platform It Was Built On

Prior authorization has a complexity problem, and the technology market's response to that problem has made it worse. As prior authorization volumes grew and administrative burden became impossible to ignore, health systems began looking for solutions — and vendors, recognizing an opportunity, began offering them. The trouble is that most of what entered the market wasn't built for prior authorization. It was built for revenue cycle management, clearinghouse processing, or practice management, and prior authorization was added when the demand signal became too loud to ignore.

‍

The result is a market full of solutions that technically include prior authorization without being genuinely built for it, and health systems that are discovering the difference six months after go-live – when the gaps between what a solution promised and what it actually delivers start showing up in unchanging denial rates, unrelieved staff capacity, and revenue walking.

‍

How Prior Authorization Became a Feature

‍

The history here is straightforward. As prior authorization volumes climbed – the average practice now completes 39 prior authorization requests per physician per week, with physicians and their staff spending approximately 13 hours per week on the process – established vendors with existing healthcare technology footprints made a logical business decision. They decided to extend the platform, acquire a point solution, add a module, and check the box on a capability that enterprise buyers were starting to require. 

‍

When regulatory requirements shift (as they are doing now with increasing frequency), payer connectivity delegations vary across national, local, and specialty-specific entities, and clinical documentation requirements are specific to payer, procedure, and specialty, it’s important that each lever receives tailored and not generic treatment. Building the intelligence to handle variability requires the kind of sustained product investment that only happens when prior auth fuels the entire roadmap, and implementation is led by deploying partners who have intricate knowledge of and dedicated time to the depths of prior auth workflow nuances.

‍

What Purpose-Built Actually Means

‍

A purpose-built solution is not a feature set. It is an architectural decision that shapes every other capability in the product. When prior authorization is the entire business — not a growth lever, not a product extension, not an acquisition — benefits compound undeniably. Payer relationships are deeper to support intentionally built product connectivity capabilities, the result of deep prior authorization workflow expertise and feasibility testing. EHR integrations are built to serve the prior authorization workflow specifically, rather than adapted from infrastructure designed for something else. And when CMS-0057 compliance timelines shift or a state legislature moves on prior authorization reform, the agility and response are measured in weeks rather than quarters because of the deeper understanding that regulatory landscape changes can cause major operational impact..

‍

The breadth of capability that becomes possible when focus is absolute shows up in the metrics. Organizations using a genuinely purpose-built approach to prior authorization see outcomes like a 96% first-pass approval rate, an 80% improvement in clinical bundling efficiency, and 83% fewer reschedules — numbers that are not achievable when clinical bundling, payer connectivity, and post-authorization monitoring are treated as secondary features rather than core engineering priorities. Initial denial rates across health systems increased 2.4% to 11.81% in 2024, and the organizations surviving the climbing rates are the ones whose authorization infrastructure was built to do exactly that.

‍

The Other Half of the Equation: People

‍

What often gets overlooked in the purpose-built conversation is that the product is only part of the story. Purpose-built extends to the entire organization behind the technology, and the distance between those two things is where bolted-on solutions tend to reveal themselves most clearly.

‍

When the vendor's entire organization is built around prior authorization – when implementation specialists understand how authorization workflows differ across radiology, oncology, infusion, and specialty pharmacy rather than running a generic onboarding playbook — the path from signed contract to realized value is fundamentally shorter. Health systems that have gone through implementations with both types of vendors describe the difference precisely: a purpose-built partner arrives knowing the workflow, knowing the payer landscape, and knowing where the friction typically lives in the first 90 days. A general-purpose vendor arrives knowing the platform.

‍

The same logic applies to customer success. A vendor whose customer success function is dedicated entirely to prior authorization outcomes has a different relationship with your performance data than one managing a portfolio of revenue cycle capabilities. They know what good looks like for your specialty mix. They can identify when automation rates are drifting before it shows up in your denial reports. And because prior authorization is the only thing they do, the institutional knowledge accumulated across their customer base is entirely applicable to your situation rather than diluted across unrelated use cases.

‍

The gap between go-live and optimized performance is real at every implementation, and it closes significantly faster when the people behind the technology understand prior authorization better than the technology itself does. That is not a soft benefit. It is a measurable operational advantage that compounds over the life of the relationship.

‍

One Thing, Done Well

‍

The prior authorization market is not short on options. What it is short on is solutions that were actually designed to solve the problem from the ground up, where every engineering decision, every payer relationship, every implementation methodology, and every customer success conversation exists for one purpose. Ninety-three percent of physicians report that prior authorization delays patient care, and 89% say it contributes to burnout — outcomes that persist, in large part, because the infrastructure built to manage prior authorization was never purpose-built to do so.

‍

For health systems actively evaluating their options, the starting question isn't which solution has the most features. It's whether prior authorization is the vendor's entire business, or whether it's a line item in a broader portfolio. The answer to that question predicts nearly everything that follows.

‍